{"id":"NCT01997411","sponsor":"Eli Lilly and Company","briefTitle":"Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes","officialTitle":"Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2013-11","primaryCompletion":"2015-01","completion":"2015-01","firstPosted":"2013-11-28","resultsPosted":"2017-03-06","lastUpdate":"2018-08-29"},"enrollment":48,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 1"],"interventions":[{"type":"DRUG","name":"Nasal Glucagon","otherNames":["AMG504-1","LY900018"]},{"type":"DRUG","name":"Intramuscular Glucagon","otherNames":["GlucaGen HypoKit"]}],"arms":[{"label":"Nasal Glucagon (NG)","type":"EXPERIMENTAL"},{"label":"Intramuscular (IM) Glucagon","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was to assess how glucagon administered nasally, using a nasal dosing delivery device, works in children and adolescents compared with commercially-available glucagon given by injection. In addition, the safety and tolerability of glucagon given nasally was evaluated.","primaryOutcome":{"measure":"Maximum Change From Baseline Concentration (Cmax) of Glucagon","timeFrame":"Pre-dose; 5, 10, 15, 20, 30, 40, 60 and 90 minutes following glucagon administration","effectByArm":[{"arm":"4 to<8 Years Old IM Glucagon Visit","deltaMin":6290.33,"sd":2045.96},{"arm":"4 to<8 Years Old NG Visit 2.0 mg","deltaMin":3463.55,"sd":1760.28},{"arm":"4 to<8 Years Old NG Visit 3.0 mg","deltaMin":3958.58,"sd":2438.6},{"arm":"8 to <12 Years Old IM Glucagon Visit","deltaMin":4743,"sd":3094.61},{"arm":"8 to<12 Years Old NG Visit 2.0 mg","deltaMin":2776.27,"sd":979.28},{"arm":"8 to<12 Years Old NG Visit 3.0 mg","deltaMin":5664.33,"sd":2114.69},{"arm":"12 to <17 Years Old IM Glucagon Visit","deltaMin":4277.25,"sd":3774.77},{"arm":"12 to<17 Years Old NG Visit 3.0 mg","deltaMin":3103.25,"sd":2302.61}],"pValues":[]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":7,"countries":["United States"]},"refs":{"pmids":["26884472"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":6},"commonTop":["Vomiting","Nausea","Headache","Injection site discomfort","Abdominal pain"]}}